These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33408715)

  • 41. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
    Roukens AHE; Pothast CR; König M; Huisman W; Dalebout T; Tak T; Azimi S; Kruize Y; Hagedoorn RS; Zlei M; Staal FJT; de Bie FJ; van Dongen JJM; Arbous SM; Zhang JLH; Verheij M; Prins C; van der Does AM; Hiemstra PS; de Vries JJC; Janse JJ; Roestenberg M; Myeni SK; Kikkert M; Yazdanbakhsh M; Heemskerk MHM; Smits HH; Jochems SP; ;
    Nat Immunol; 2022 Jan; 23(1):23-32. PubMed ID: 34937933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization.
    Spencer DM; Belshaw PJ; Chen L; Ho SN; Randazzo F; Crabtree GR; Schreiber SL
    Curr Biol; 1996 Jul; 6(7):839-47. PubMed ID: 8805308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype.
    Gougeon ML; Lecoeur H; Boudet F; Ledru E; Marzabal S; Boullier S; Roué R; Nagata S; Heeney J
    J Immunol; 1997 Mar; 158(6):2964-76. PubMed ID: 9058836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PD-1-Mediated PI3K/Akt/mTOR, Caspase 9/Caspase 3 and ERK Pathways Are Involved in Regulating the Apoptosis and Proliferation of CD4
    Liu Y; Liu S; Wu C; Huang W; Xu B; Lian S; Wang L; Yue S; Chen N; Zhu Z
    Front Immunol; 2020; 11():467. PubMed ID: 32256500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD3
    Ivanova OK; Sharapova TN; Romanova EA; Soshnikova NV; Sashchenko LP; Yashin DV
    J Cell Biochem; 2017 Oct; 118(10):3359-3366. PubMed ID: 28294381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apoptosis regulators Fas and Bim synergistically control T-lymphocyte homeostatic proliferation.
    Fortner KA; Bouillet P; Strasser A; Budd RC
    Eur J Immunol; 2010 Nov; 40(11):3043-53. PubMed ID: 21061436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High Frequencies of Functional Virus-Specific CD4
    Mele D; Calastri A; Maiorano E; Cerino A; Sachs M; Oliviero B; Mantovani S; Baldanti F; Bruno R; Benazzo M; Grifoni A; Sette A; Mondelli MU; Varchetta S
    Front Immunol; 2021; 12():748881. PubMed ID: 34858405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional state of CD4+ and CD8+ T lymphocytes and their role in the slow progression of HIV infection in pediatric patients.
    Alfonzo MA; Diaz A; Siciliano L; López MG; Hung A; Garcia JF
    J Pediatr (Rio J); 2012; 88(2):161-8. PubMed ID: 22543625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aberrant T-cell activation via CD95 and apoptosis in peripheral T lymphocytes in stable heart transplant recipients.
    Ankersmit HJ; Moser B; Hoffman M; Kocher AA; Schlechta B; Boltz-Nitulescu G; Wolner E
    Transplant Proc; 2001 Aug; 33(5):2860-1. PubMed ID: 11498190
    [No Abstract]   [Full Text] [Related]  

  • 50. Induction of CD95 ligand expression on T lymphocytes and B lymphocytes and its contribution to apoptosis of CD95-up-regulated CD4+ T lymphocytes in macaques by infection with a pathogenic simian/human immunodeficiency virus.
    Sasaki Y; Ami Y; Nakasone T; Shinohara K; Takahashi E; Ando S; Someya K; Suzaki Y; Honda M
    Clin Exp Immunol; 2000 Dec; 122(3):381-9. PubMed ID: 11122244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD4+ cells play a major role in xenogeneic human anti-pig cytotoxicity through the Fas/Fas ligand lytic pathway.
    Yi S; Feng X; Wang Y; Kay TW; Wang Y; O'Connell PJ
    Transplantation; 1999 Feb; 67(3):435-43. PubMed ID: 10030292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increase in CD95 (Fas/APO-1)-positive CD4+ and CD8+ T cells in peripheral blood derived from patients with autoimmune hepatitis or chronic hepatitis C with autoimmune phenomena.
    Ogawa S; Sakaguchi K; Takaki A; Shiraga K; Sawayama T; Mouri H; Miyashita M; Koide N; Tsuji T
    J Gastroenterol Hepatol; 2000 Jan; 15(1):69-75. PubMed ID: 10719750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of SARS-CoV-2 variants on the total CD4
    Tarke A; Sidney J; Methot N; Yu ED; Zhang Y; Dan JM; Goodwin B; Rubiro P; Sutherland A; Wang E; Frazier A; Ramirez SI; Rawlings SA; Smith DM; da Silva Antunes R; Peters B; Scheuermann RH; Weiskopf D; Crotty S; Grifoni A; Sette A
    Cell Rep Med; 2021 Jul; 2(7):100355. PubMed ID: 34230917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulatory CD4
    Gao M; Liu Y; Guo M; Wang Q; Wang Y; Fan J; Shen Y; Hou J; Wan Y; Zhu Z
    J Leukoc Biol; 2021 Jan; 109(1):91-97. PubMed ID: 32930458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells.
    Gehri R; Hahn S; Rothen M; Steuerwald M; Nuesch R; Erb P
    AIDS; 1996 Jan; 10(1):9-16. PubMed ID: 8924258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.
    D'Souza AD; Parish IA; McKay SE; Kaech SM; Shadel GS
    Am J Pathol; 2011 Jun; 178(6):2740-51. PubMed ID: 21641396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
    Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
    Front Immunol; 2021; 12():684014. PubMed ID: 34194438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment.
    Kim N; Lee JM; Oh EJ; Jekarl DW; Lee DG; Im KI; Cho SG
    Front Immunol; 2021; 12():751869. PubMed ID: 35003063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD4
    Popescu I; Snyder ME; Iasella CJ; Hannan SJ; Koshy R; Burke R; Das A; Brown MJ; Lyons EJ; Lieber SC; Chen X; Sembrat JC; Bhatt P; Deng E; An X; Linstrum K; Kitsios G; Konstantinidis I; Saul M; Kass DJ; Alder JK; Chen BB; Lendermon EA; Kilaru S; Johnson B; Pilewski JM; Kiss JE; Wells AH; Morris A; McVerry BJ; McMahon DK; Triulzi DJ; Chen K; Sanchez PG; McDyer JF
    Am J Respir Crit Care Med; 2022 Jun; 205(12):1403-1418. PubMed ID: 35348444
    [No Abstract]   [Full Text] [Related]  

  • 60. Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients.
    Gozzi-Silva SC; Oliveira LM; Alberca RW; Pereira NZ; Yoshikawa FS; Pietrobon AJ; Yendo TM; de Souza Andrade MM; Ramos YAL; Brito CA; Oliveira EA; Beserra DR; Orfali RL; Aoki V; Duarte AJDS; Sato MN
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.